KALA BIO, Inc.: 10-Q filed 2026-08-19
What KALA BIO, Inc. reported in its quarterly report filed 2026-08-19 (fiscal Q2 2026): 33 published measures, 91 facts as tagged in accession 0001104659-26-098783.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2026-08-19
- Fiscal period
- fiscal Q2 2026
- Accession
- 0001104659-26-098783 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KALA BIO, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 10,582,000 | USD | |
| At 2025-12-31 | 9,490,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,538,000 | USD | |
| At 2025-12-31 | 2,494,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 9,044,000 | USD | |
| At 2026-03-31 | 10,761,000 | USD | |
| At 2025-12-31 | 6,996,000 | USD | |
| At 2025-06-30 | -3,206,000 | USD | |
| At 2025-03-31 | 5,708,000 | USD | |
| At 2024-12-31 | 12,332,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 229,000 | USD | |
| At 2025-12-31 | 7,557,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -1,581,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -3,202,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -11,155,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -20,102,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -4,430,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -16,558,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 4,102,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -2,665,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -7,000,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -16,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | -698,102,000 | USD | |
| At 2025-12-31 | -694,900,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 74,159 | shares | 91 |
| 2026-01-01 to 2026-06-30 | 15,287,538 | shares | 181 |
| 2025-04-01 to 2025-06-30 | 130,262 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 128,599 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 74,159 | shares | 91 |
| 2026-01-01 to 2026-06-30 | 15,287,538 | shares | 181 |
| 2025-04-01 to 2025-06-30 | 130,262 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 128,599 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -21.32 | USD/shares | 91 |
| 2026-01-01 to 2026-06-30 | -0.21 | USD/shares | 181 |
| 2025-04-01 to 2025-06-30 | -85.64 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -156.32 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -21.32 | USD/shares | 91 |
| 2026-01-01 to 2026-06-30 | -0.21 | USD/shares | 181 |
| 2025-04-01 to 2025-06-30 | -85.64 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -156.32 | USD/shares | 181 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -607,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 4,550,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -1,721,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -3,523,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -11,028,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -21,697,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 10,582,000 | USD | |
| At 2025-12-31 | 9,490,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,538,000 | USD | |
| At 2025-12-31 | 2,494,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,142,000 | USD | |
| At 2025-12-31 | 986,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 1,721,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 3,523,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 11,028,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 21,697,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 59,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 120,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 6,232,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 12,287,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 19,339,786 | shares | |
| At 2025-12-31 | 556,995 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 707,126,000 | USD | |
| At 2025-12-31 | 701,894,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 3,353,000 | USD | |
| At 2025-12-31 | 1,933,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -3,202,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -20,102,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -1,581,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -3,202,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -11,155,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -20,102,000 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -1,581,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -3,202,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -11,155,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -20,102,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 1,662,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 3,403,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 4,643,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 9,236,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 135,000 | USD | 181 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-04-01 to 2025-06-30 | 1,081,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 2,172,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 107,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 140,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 321,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -127,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 1,595,000 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-06-30 | 1,853,000 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 156,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 30,000 | USD | 181 |
Inspect the source
- Entity
- KALA BIO, Inc. / CIK 0001479419
- Captured
- 2026-09-20T09:08:47.092Z
- SEC response SHA-256
29f0e958f07019914b4cd1bb8afa2c4b328082c5da8bf6fe4452eddabcaf41d1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001479419.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))